COPD Assessment Test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross-sectional study

Respirology

Volumn 22, Issue 4, 2017, Pages 721-727

  Matsuda, Toshiaki ^a,c   Taniguchi, Hiroyuki ^a   Ando, Masahiko ^b   Kondoh, Yasuhiro ^a   Kimura, Tomoki ^a   Kataoka, Kensuke ^a   Sakamoto, Koji ^c   Suzuki, Atsushi ^a   Furukawa, Taiki ^a   Hasegawa, Yoshinori ^c  

^a TOSEI GENERAL HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

chronic obstructive pulmonary disease Assessment Test; health status; idiopathic pulmonary fibrosis; St George's Respiratory Questionnaire

Indexed keywords

ADULT; AGED; ANXIETY; ARTERIAL OXYGEN TENSION; ARTICLE; CONCURRENT VALIDITY; CONSTRUCT VALIDITY; COPD ASSESSMENT TEST; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FIBROSING ALVEOLITIS; HEALTH STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT REPEATABILITY; MODIFIED MEDICAL RESEARCH COUNCIL DYSPNEA SCALE; OXYGEN SATURATION; RESPIRATORY TRACT DISEASE ASSESSMENT; SIX MINUTE WALK TEST; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPLICATION; LUNG FUNCTION TEST; MIDDLE AGED; PATHOPHYSIOLOGY; QUESTIONNAIRE; REGRESSION ANALYSIS; REPRODUCIBILITY;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; SURVEYS AND QUESTIONNAIRES;

EID: 85001807238     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12936     Document Type: Article

References (39)

1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA et al.; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788–824.
2. Natsuizaka M, Chiba H, Kuronuma K, Otsuka M, Kudo K, Mori M, Bando M, Sugiyama Y, Takahashi H. Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences. Am. J. Respir. Crit. Care Med. 2014; 190: 773–9.
3. Chang JA, Curtis JR, Patrick DL, Raghu G. Assessment of health-related quality of life in patients with interstitial lung disease. Chest 1999; 116: 1175–82.
4. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y et al.; INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N. Engl. J. Med. 2014; 370: 2071–82.
5. Belkin A, Swigris JJ. Health-related quality of life in idiopathic pulmonary fibrosis: where are we now? Curr. Opin. Pulm. Med. 2013; 19: 474–9.
6. Swigris JJ, Esser D, Conoscenti CS, Brown KK. The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review. Health Qual. Life Outcomes 2014; 12: 124.
7. Ferrer M, Villasante C, Alonso J, Sobradillo V, Gabriel R, Vilagut G, Masa JF, Viejo JL, Jimenez-Ruiz CA, Miravitlles M. Interpretation of quality of life scores from the St George's Respiratory Questionnaire. Eur. Respir. J. 2002; 19: 405–13.
8. Ringbaek T, Martinez G, Lange P. A comparison of the assessment of quality of life with CAT, CCQ, and SGRQ in COPD patients participating in pulmonary rehabilitation. COPD 2012; 9: 12–5.
9. Tsuda T, Suematsu R, Kamohara K, Kurose M, Arakawa I, Tomioka R, Kawayama T, Hoshino T, Aizawa H. Development of the Japanese version of the COPD Assessment Test. Respir. Investig. 2012; 50: 34–9.
10. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur. Respir. J. 2009; 34: 648–54.
11. Nagata K, Tomii K, Otsuka K, Tachikawa R, Otsuka K, Takeshita J, Tanaka K, Matsumoto T, Monden K. Evaluation of the chronic obstructive pulmonary disease assessment test for measurement of health-related quality of life in patients with interstitial lung disease. Respirology 2012; 17: 506–12.
12. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P et al.; ATS/ERS Task Force. Standardisation of spirometry. Eur. Respir. J. 2005; 26: 319–38.
13. Guideline of respiratory function tests--spirometry, flow-volume curve, diffusion capacity of the lung. Nihon Kokyuki Gakkai Zasshi 2004; (Suppl.): 1–56.
14. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Kataoka K, Ogawa T, Watanabe F, Arizono S. A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis. Eur. Respir. J. 2010; 36: 1067–72.
15. Mura M, Porretta MA, Bargagli E, Sergiacomi G, Zompatori M, Sverzellati N, Taglieri A, Mezzasalma F, Rottoli P, Saltini C et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study. Eur. Respir. J. 2012; 40: 101–9.
16. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 1998; 157: 785–90.
17. Miravitlles M, Soriano JB, Garcia-Rio F, Munoz L, Duran-Tauleria E, Sanchez G, Sobradillo V, Ancochea J. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64: 863–8.
18. Matsudaira T, Igarashi H, Kikuchi H, Kano R, Mitoma H, Ohuchi K, Kitamura T. Factor structure of the Hospital Anxiety and Depression Scale in Japanese psychiatric outpatient and student populations. Health Qual. Life Outcomes 2009; 7: 42.
19. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 1983; 67: 361–70.
20. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166: 111–7.
21. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, Murray S, Kazerooni EA, Gross BH, Lynch JP 3rd et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2003; 168: 1084–90.
22. Jones PW, Shahrour N, Nejjari C, Lahlou A, Doble A, Rashid N, El Hasnaoui A BREATHE Study Group. Psychometric evaluation of the COPD assessment test: data from the BREATHE study in the Middle East and North Africa region. Respir. Med. 2012; 106(Suppl. 2): S86–99.
23. Lari SM, Ghobadi H, Attaran D, Mahmoodpour A, Shadkam O, Rostami M. COPD assessment test (CAT): simple tool for evaluating quality of life of chemical warfare patients with chronic obstructive pulmonary disease. Clin. Respir. J. 2014; 8: 116–23.
24. Swigris JJ, Kuschner WG, Jacobs SS, Wilson SR, Gould MK. Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 2005; 60: 588–94.
25. Martinez FJ, Safrin S, Weycker D, Starko KM, Bradford WZ, King TE Jr, Flaherty KR, Schwartz DA, Noble PW, Raghu G et al.; IPF Study Group. The clinical course of patients with idiopathic pulmonary fibrosis. Ann. Intern. Med. 2005; 142: 963–7.
26. Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Ogawa T, Watanabe F, Nishimura K. Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor? Respir. Med. 2005; 99: 408–14.
27. Tzanakis N, Samiou M, Lambiri I, Antoniou K, Siafakas N, Bouros D. Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur. J. Intern. Med. 2005; 16: 105–12.
28. Peng S, Li Z, Kang J, Hou X. Cross-sectional and longitudinal construct validity of the Saint George's Respiratory Questionnaire in patients with IPF. Respirology 2008; 13: 871–9.
29. Hallstrand TS, Boitano LJ, Johnson WC, Spada CA, Hayes JG, Raghu G. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur. Respir. J. 2005; 25: 96–103.
30. Enright PL. The six-minute walk test. Respir. Care 2003; 48: 783–5.
31. Lee AS, Mira-Avendano I, Ryu JH, Daniels CE. The burden of idiopathic pulmonary fibrosis: an unmet public health need. Respir. Med. 2014; 108: 955–67.
32. De Vries J, Kessels BL, Drent M. Quality of life of idiopathic pulmonary fibrosis patients. Eur. Respir. J. 2001; 17: 954–61.
33. Doyle T, Palmer S, Johnson J, Babyak MA, Smith P, Mabe S, Welty-Wolf K, Martinu T, Blumenthal JA. Association of anxiety and depression with pulmonary-specific symptoms in chronic obstructive pulmonary disease. Int. J. Psychiatry Med. 2013; 45: 189–202.
34. Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim. Care Respir. J. 2011; 20: 257–68.
35. Pumar MI, Gray CR, Walsh JR, Yang IA, Rolls TA, Ward DL. Anxiety and depression-important psychological comorbidities of COPD. J. Thorac. Dis. 2014; 6: 1615–31.
36. Yorke J, Moosavi SH, Shuldham C, Jones PW. Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnea-12. Thorax 2010; 65: 21–6.
37. Yorke J, Swigris J, Russell AM, Moosavi SH, Ng Man Kwong G, Longshaw M, Jones PW. Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. Chest 2011; 139: 159–64.
38. Patel AS, Siegert RJ, Brignall K, Gordon P, Steer S, Desai SR, Maher TM, Renzoni EA, Wells AU, Higginson IJ et al. The development and validation of the King's Brief Interstitial Lung Disease (K-BILD) health status questionnaire. Thorax 2012; 67: 804–10.
39. Karloh M, Fleig Mayer A, Maurici R, Pizzichini MM, Jones PW, Pizzichini E. The COPD Assessment Test: what do we know so far?: a systematic review and meta-analysis about clinical outcomes prediction and classification of patients into GOLD stages. Chest 2016; 149: 413–25.